UFSK International OSYS Gmbh Kirchhoffstr. 1 Ratisbon Germany UFSK Treatment chair 500 XLE- Treatment chair for positioning and support of the patient during diagnostic and therapeutic treatments of temporary to short-term duration, especially in ophthalmology Art.no. / REF no.: 15000004 Art.no. / REF no.: 15000006 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
UFSK Treatment chair 500 XLE- Treatment chair for positioning and support of the patient during diagnostic and therapeutic treatments of temporary to short-term duration, especially in ophthalmology Art.no. / REF no.: 15000004 Art.no. / REF no.: 15000006
Brand
UFSK International OSYS Gmbh Kirchhoffstr. 1 Ratisbon Germany
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Art.no. / REF no.: 15000004 Serial number range: 2000- 2999 Art.no. / REF no.: 15000006 Serial number range: 3000-4506
UFSK International OSYS Gmbh Kirchhoffstr. 1 Ratisbon Germany is recalling UFSK Treatment chair 500 XLE- Treatment chair for positioning and support of the patient during diag due to Service life of the electrical seat part drive of the treatment chair may be shortened unexpectedly after several years of use due to a potential wear. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Service life of the electrical seat part drive of the treatment chair may be shortened unexpectedly after several years of use due to a potential wear-related reduction in the self-locking of the drive and may remain undetected. A worsened self-locking of the seat drive can lead to overriding the drive s end position when positioning the patient with the seat part in an inclined position
Recommended Action
Per FDA guidance
UFSK email issued to distributors on May 3, 2023 action to take: 1a) distributor has to check their stock and quarantine affected chairs 1b) distributor has to identify customers who received treatment chairs with affected serial numbers 1c) distributor has to confirm via reply form to UFSK, that he has received and understood the action and will forward the safety notice to his customers. Distributors issued Urgent Medical Device Correction via email to Customers on May 31, 2023. Letter states reason for recall, health risk and action to take: Restricted use instructions as follows: The seat part drive is to be retracted so far with the patient in position that the seat part is in a horizontal position. Then the seat part may no longer be adjusted with the positioned patient. Attach the safety notice to the instructions for use of the respective treatment chair. Label the treatment chair appropriately using the information in the attachment to ensure safe use by changing users. If the seat drive is replaced, the backward inclination of the seat section can be used again. Follow-up measures: 7a) We urgently recommend to replace the seat part drive at the latest when the next safety inspection is carried out (interval 12 months). A replacement drive can be installed easily and without great effort. The successor model of the drive has a technically advanced self-locking mechanism for the motor and a mechanical end stop. The risk of the seat drive overrunning its end position due to wear when the seat section is tilted is then absolutely minimized. 7b) Update 500 XLE user & service manual with enclosed supplement. New contents: service plan for safety-relevant component, amended spare part list and installation instructions for the spare part drive. see document attached: Add_Manual_97000017_500XLE_SN2000-4506_40002535_230530_EN.pdf. Please contact UFSK-OSYS authorized US-Importer and distributor: Nautilus Surgical Inc., 2520 Horse Pasture Road Suite 103, Virgini
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026